Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman A Blaheta

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
BMC Cancer|January 13, 2005
Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancyTobias Engl, Jasmina Makarević, Borna Relja, et al.
International Journal of Molecular Medicine|March 9, 2005
Modulation of the CXC-chemokine expression profile on tumor cells by the immunosuppressive drug mycophenolate mofetilTobias Engl, Borna Relja, Iyad Natsheh, et al.
Life Sciences|January 4, 2011
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Complementary Therapies in Medicine|April 3, 2019
Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administrationJens Mani, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers|January 21, 2022
Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent MechanismCarolin Siech, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers|June 7, 2019
Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In VitroEva Juengel, Iyad Natsheh, Ramin Najafi, et al.
Oncotarget|January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cellsEva Juengel, Ramin Najafi, Jochen Rutz, et al.
International Journal of Molecular Medicine|January 20, 2016
Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanismEva Juengel, Masud Afschar, Jasmina Makarević, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2007
Long-term production of major coagulation factors and inhibitors by primary human hepatocytes in vitro: perspectives for clinical applicationKim A Boost, Marcus K H Auth, Dirk Woitaschek, et al.
Plos One|August 20, 2014
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
BMC Cancer|January 13, 2005
Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancyTobias Engl, Jasmina Makarević, Borna Relja, et al.
International Journal of Molecular Medicine|March 9, 2005
Modulation of the CXC-chemokine expression profile on tumor cells by the immunosuppressive drug mycophenolate mofetilTobias Engl, Borna Relja, Iyad Natsheh, et al.
Life Sciences|January 4, 2011
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Complementary Therapies in Medicine|April 3, 2019
Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administrationJens Mani, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers|January 21, 2022
Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent MechanismCarolin Siech, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers|June 7, 2019
Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In VitroEva Juengel, Iyad Natsheh, Ramin Najafi, et al.
Oncotarget|January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cellsEva Juengel, Ramin Najafi, Jochen Rutz, et al.
International Journal of Molecular Medicine|January 20, 2016
Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanismEva Juengel, Masud Afschar, Jasmina Makarević, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2007
Long-term production of major coagulation factors and inhibitors by primary human hepatocytes in vitro: perspectives for clinical applicationKim A Boost, Marcus K H Auth, Dirk Woitaschek, et al.
Plos One|August 20, 2014
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Pageof 13